Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Tango Therapeutics (TNGX) Receivables - Net (2020 - 2022)

Tango Therapeutics has reported Receivables - Net over the past 3 years, most recently at $2.0 million for Q4 2022.

  • Quarterly results put Receivables - Net at $2.0 million for Q4 2022, changed 0.0% from a year ago — trailing twelve months through Dec 2022 was $2.0 million (changed 0.0% YoY), and the annual figure for FY2022 was $2.0 million, changed 0.0%.
  • Receivables - Net for Q4 2022 was $2.0 million at Tango Therapeutics, roughly flat from $2.0 million in the prior quarter.
  • Over the last five years, Receivables - Net for TNGX hit a ceiling of $8.0 million in Q3 2021 and a floor of $2.0 million in Q4 2020.
  • Median Receivables - Net over the past 3 years was $2.0 million (2020), compared with a mean of $2.9 million.
  • Biggest five-year swings in Receivables - Net: changed 0.0% in 2021 and later crashed 75.0% in 2022.
  • Tango Therapeutics' Receivables - Net stood at $2.0 million in 2020, then changed by 0.0% to $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022.
  • The last three reported values for Receivables - Net were $2.0 million (Q4 2022), $2.0 million (Q3 2022), and $2.0 million (Q2 2022) per Business Quant data.